当前位置:首页 - 行情中心 - 富森美(002818) - 财务分析 - 利润表

富森美

(002818)

  

流通市值:32.49亿  总市值:81.51亿
流通股本:2.98亿   总股本:7.48亿

利润表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、营业总收入1,199,167,708.57924,192,679.18648,800,315.8329,927,635.02
  营业收入1,199,167,708.57924,192,679.18648,800,315.8329,927,635.02
二、营业总成本592,025,541.27429,954,529.22283,817,709.24136,764,157.05
  营业成本444,186,733.07320,172,367.91207,968,052.7899,009,108.32
  税金及附加82,400,970.9863,403,951.144,178,767.9222,622,983.01
  销售费用5,653,473.014,277,522.592,793,204.681,205,372.37
  管理费用59,751,963.6842,216,811.6929,131,159.6314,105,736.3
  财务费用32,400.53-116,124.07-253,475.77-179,042.95
  其中:利息费用514,676.29399,404.06273,294.45135,550
  其中:利息收入1,229,608.461,086,423.08903,445.02412,547.62
三、其他经营收益
  加:公允价值变动收益-16,346,504.8129,165,127.07-19,658,212.37-31,664,840.82
  加:投资收益72,222,776.8345,139,248.4540,040,629.0620,007,194.34
  资产处置收益752.22-685.83-685.83-
  资产减值损失(新)3,471,188.5-1,189,508.17-1,321,882.32-1,290,136.48
  信用减值损失(新)-7,512,708.3-474,433.5-2,433,312.92-4,429,316.96
  其他收益1,992,075.831,168,125.57734,943.31493,373.82
四、营业利润660,969,747.57568,046,023.55382,344,085.49176,279,751.87
  加:营业外收入1,422,460.521,135,273.27531,303.82173,705.15
  减:营业外支出281,625.41168,424.6663,843.2962,751.23
五、利润总额662,110,582.68569,012,872.16382,811,546.02176,390,705.79
  减:所得税费用94,077,286.8981,747,159.9352,823,546.6823,471,203.35
六、净利润568,033,295.79487,265,712.23329,987,999.34152,919,502.44
(一)按经营持续性分类
  持续经营净利润568,033,295.79487,265,712.23329,987,999.34152,919,502.44
(二)按所有权归属分类
  归属于母公司股东的净利润555,491,289.89477,302,662.93318,240,499.8147,863,965.75
  少数股东损益12,542,005.99,963,049.311,747,499.545,055,536.69
  扣除非经常损益后的净利润538,018,274.41437,624,692.18326,677,705.73170,740,330.86
七、每股收益
  (一)基本每股收益0.740.640.430.2
  (二)稀释每股收益0.740.640.430.2
九、综合收益总额568,033,295.79487,265,712.23329,987,999.34152,919,502.44
  归属于母公司股东的综合收益总额555,491,289.89477,302,662.93318,240,499.8147,863,965.75
  归属于少数股东的综合收益总额12,542,005.99,963,049.311,747,499.545,055,536.69
公告日期2026-03-312025-10-282025-08-282025-04-29
审计意见(境内)标准无保留意见
TOP↑